Editorial: Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery – Part I

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|19|3|236-237

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.19, Iss.3, 2018-01, pp. : 236-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial; Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery – Part II

By  

Current Protein and Peptide Science, Vol. 19, Iss. 4, 2018-02 ,pp. : 342-342

Bentham Science Publishers

Access to resources Recommend Favorite

Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery

By  

Current Protein and Peptide Science, Vol. 19, Iss. 3, 2018-01 ,pp. : 292-301

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Natural Proteasome Inhibitors as Novel Anticancer Therapeutics: Current Status and Perspectives

By  

Current Protein and Peptide Science, Vol. 19, Iss. 4, 2018-02 ,pp. : 358-367

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents

By  

Current Protein and Peptide Science, Vol. 19, Iss. 3, 2018-01 ,pp. : 333-340

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase as target for antibacterial and anticancer drug discovery

By Kathiravan Muthu K.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 3, 2013-06 ,pp. : 419-435

Informa Healthcare

Access to resources Recommend Favorite